Home » Authors » Anette Breindl

Articles by Anette Breindl

Studying Receptor Function Yielding Targets For Disease

April 19, 2006

By Anette Breindl

Viral, Host Receptor Studies Suggest Kaposi's Therapies

April 18, 2006

By Anette Breindl

Viral, Host Receptor Studies Suggest Kaposi's Therapies

April 18, 2006

By Anette Breindl

New Channel Mutations Seen As Neurodegeneration Cause

April 14, 2006

By Anette Breindl

New Channel Mutations Seen As Neurodegeneration Cause

April 14, 2006

By Anette Breindl

Bioreactor To Bedside, Metastasis In Crosshairs

April 7, 2006

By Anette Breindl

Bioreactor To Bedside, Metastasis In Crosshairs

April 7, 2006

By Anette Breindl

Stapling Synthetic Biologics To Attack Difficult Cancer Targets

April 5, 2006

By Anette Breindl

Stapling Synthetic Biologics To Attack Difficult Cancer Targets

April 5, 2006

By Anette Breindl

Cancer Drug Developers Running Out Of Excuses

April 4, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...